Ammonul Related Published Studies
Research related to Ammonul (Sodium Phenylacetate / Sodium Benzoate)
Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers. [2004.04]
Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia. [2000.03]
Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate. [1997.12]
Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse. [1988.04]
Other possibly related research studies
Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. [2004.04]
Alternative pathway therapy for urea cycle disorders: twenty years later. [2001.01]
Current strategies for the management of neonatal urea cycle disorders. [2001.01]
Successful use of alternate waste nitrogen agents and hemodialysis in a patient with hyperammonemic coma after heart-lung transplantation. [1999.04]
Long-term treatment of girls with ornithine transcarbamylase deficiency. [1996.09.19]
Late clinical presentation of partial carbamyl phosphate synthetase I deficiency. [1993.03]
Prospective management of a child with neonatal citrullinemia. [1993.01]
Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonaemia in two sisters with carbamyl phosphate synthetase deficiency. [1992]
Hyperammonemia following allogeneic bone marrow transplantation. [1991.10]
N-acetylglutamate synthetase deficiency: clinical and laboratory observations. [1991]
Hyperammonaemic coma in ureterosigmoid urinary diversion. [1989.07]
Treatment of urea cycle disorders. [1987]
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. [2007.05.31]
Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration. [2007.07]
Gateways to clinical trials. [2007.11]
Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. [2008.10]
Favorable effect of 4-phenylacetate on liver functions attributable to enhanced bile salt export pump expression in ornithine transcarbamylase-deficient children. [2010.06]
Phenylbutyrate therapy for maple syrup urine disease. [2011.02.15]
Ammonia toxicity and its prevention in inherited defects of the urea cycle. [2009.09]
|
